Drugs by condition
Drugs approved for cushing's syndrome
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
0
Still marketed, NDA or BLA
Drug classes
0
Novel drugs
0
New molecular entities and new biologics
In development
3
Investigational drugs in Phase 2 or 3
All approved drugs for cushing's syndrome, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
No current brand-name label names this in its indications. Try another name for the condition, or a broader term.
Drugs in development for cushing's syndrome
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- CRN04894AtumelnantPhase 35 trials
Crinetics Pharmaceuticals Inc. · Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia, Cushing Syndrome
- Lu AG13909AsedebartPhase 23 trials
H. Lundbeck A/S · Cushing's Disease, Congenital Adrenal Hyperplasia, Adrenal Hyperplasia, Congenital
- SPI-62clofutriben, ASP3662Phase 23 trials
Sparrow Pharmaceuticals · Cortisol Excess, Type 2 Diabetes, Polymyalgia Rheumatica
More on cushing's syndrome: recruiting trials · published research
Related in endocrinology and women's health: Hypothyroidism · Osteoporosis · Menopause symptoms · Endometriosis · Uterine fibroids · Birth control · Low testosterone · Growth hormone deficiency · Acromegaly
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.